Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
LOCKHEED MARTIN CORPORATION	LMT	Buenos Aires S.E. +1 Other	1,017	25,675 ARS	Stock
LOCKHEED MARTIN CORPORATION	LMTD	Buenos Aires S.E.	158	25.6 USD
LOCKHEED MARTIN CORPORATION	LMTB34	Sao Paulo	32	2,380 BRL	Stock
LOCKHEED MARTIN CORPORATION	LMT	Nyse +11 Other	784,659	466.2 USD	Stock
LOCKHEED MARTIN CORPORATION	LOM	Deutsche Boerse AG	83	427.4 EUR
LOCKHEED MARTIN CORPORATION	LOM	Frankfurt	561	426.8 EUR
LOCKHEED MARTIN CORPORATION	LMT *	Mexican S.E.	301	7,700 MXN
LOCKHEED MARTIN CORPORATION	LMT	Swiss Exchange	-	430 CHF
LOCKHEED MARTIN CORPORATION	0R3E	London S.E.	131	469.9 USD
LOCKHEED MARTIN CORPORATION	LMT	Wiener Boerse	9	426.9 EUR
LOCKHEED MARTIN CORPORATION	LOM	Börse Stuttgart	25	428.2 EUR
LOCKHEED MARTIN CORPORATION	LOM	BOERSE MUENCHEN	199	428 EUR
LOCKHEED MARTIN CORPORATION	4LMT	Borsa Italiana	-	428.8 EUR
LOCKHEED MARTIN CORPORATION	LMT	Berne S.E.	3	414 CHF
LOCKHEED MARTIN CORPORATION	LOM	Bulgaria S.E.	1	439.1 EUR
MARTIN MARIETTA MATERIALS, INC.	MLM	Nyse +6 Other	451,843	580.8 USD	Stock
MARTIN MARIETTA MATERIALS, INC.	MMX	Deutsche Boerse AG	-	534.4 EUR
MARTIN MARIETTA MATERIALS, INC.	MLM *	Mexican S.E.	16	10,105 MXN
MARTIN MARIETTA MATERIALS, INC.	MMX	Börse Stuttgart	-	533.2 EUR
MARTIN MARIETTA MATERIALS, INC.	0JZ0	London S.E.	55	584.8 USD
MARTIN MARIETTA MATERIALS, INC.	MMX	BOERSE MUENCHEN	-	533.2 EUR
MARTIN MARIETTA MATERIALS, INC.	MMX	Berne S.E.	-	- CHF
MAINSTAY MACKAY DEFINEDTERM MUNICIPAL OPPORTUNITIES FUND	MMD	Nyse	57,946	16.5 USD	Stock
USHA MARTIN LIMITED	USHAMART	Bombay S.E. +1 Other	91,753	357.8 INR	Stock
USHA MARTIN LIMITED	USHAMART	NSE India S.E.	1,675,002	357.8 INR
MARTIN BURN LIMITED	MARBU6	Bombay S.E.	1,525	50.82 INR	Stock
USHA MARTIN LIMITED	USHMA	LUXEMBOURG S.E.	-	21.2 USD	Stock
MARTIN MIDSTREAM PARTNERS L.P.	MMLP	Nasdaq	66,919	3.02 USD	Stock
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	AML	London S.E. +6 Other	1,553,395	141.2 GBX	Stock
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	A5S	Deutsche Boerse AG	8,715	2.16 EUR
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	A5SA	Börse Stuttgart	-	1.615 EUR
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	A5SA	BOERSE MUENCHEN	6,915	1.679 EUR
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	A5SA	Deutsche Boerse AG	10,987	1.68 EUR
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	AMGDF	OTC Markets	8,381	1.76 USD
ASTON MARTIN LAGONDA GLOBAL HOLDINGS PLC	AML N	Mexican S.E.	-	39.62 MXN

See all

News (548)

Ameren : Sustainability Presentation	05-08	PU
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024	04-24	PU
Cognizant Technology : 2023 Annual Report 2024 Proxy Statement	04-23	PU
Transcript : Kinder Morgan, Inc., Q1 2024 Earnings Call, Apr 17, 2024	04-17
Resolutions from the Annual General Meeting of Novo Nordisk A/S	03-21	AQ
Resolutions from the Annual General Meeting of Novo Nordisk A/S	03-21	GL
Transcript : Novo Nordisk A/S - Shareholder/Analyst Call	03-21
Durango Intersects Lithium in Pegmatite at NMX East Lithium Property	03-01	AQ
Durango Provides Discovery Property Update	02-28	AQ
Notice for the Annual General Meeting of Novo Nordisk A/S	02-21	GL
Novo Nordisk : Proxy / voting by correspondence form	02-19	PU
Novo Nordisk : ADR Holders – proxy mailing	02-19	PU
Atacama Copper Corporation Announces Completion of Business Transaction with TCP1	02-13	NE
TCP1 Corporation completed the acquisition of Atacama Copper Corporation in a reverse merger transaction.	02-08	CI
Transcript : Kinder Morgan, Inc. - Analyst/Investor Day	01-24
Transcript : Kinder Morgan, Inc., Q4 2023 Earnings Call, Jan 17, 2024	01-17
Transcript : Rallybio Corporation - Special Call	12-20
Transcript : Aris Water Solutions, Inc., Q3 2023 Earnings Call, Nov 02, 2023	11-02
Transcript : Southern Cross Media Group Limited - Shareholder/Analyst Call	23-10-26
TCP1 Corporation signed a binding letter of intent to acquire Atacama Copper Corporation for CAD 47.8 million in a reverse merger transaction.	23-10-26	CI
Interfor Appoints Geoffrey Evans to its Board of Directors	23-10-25	GL
Interfor Appoints Geoffrey Evans to its Board of Directors	23-10-25	AQ
Botswana Insurance : NOTICE TO SHAREHOLDERS - UNCLAIMED DIVIDENDS	23-09-28	PU
Swiss-based trader IXM cuts several metals traders in major reshuffle	23-09-28	RE
Giga Metals – Voting Results	23-09-11	GL
Companhia de Saneamento Básico do Estado de São Paulo SABESP : MINUTES OF THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF AUGUST 22, 2023 - Form 6-K	23-09-05	PU
Rallybio to Present at Upcoming Investor Conferences in September	23-08-31	BU
Giga Metals : 2023 Proxy Form	23-08-11	PU
Giga Metals : 2023 Voting Instruction Form	23-08-11	PU
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates	23-08-08	BU
Rallybio Announces Succession Plan, Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023	23-06-30	AQ
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023	23-06-29	BU
Transcript : Rallybio Corporation - Shareholder/Analyst Call	23-06-24
Transcript : MTN Group Limited - Analyst/Investor Day	23-05-31
Companhia de Saneamento Básico do Estado de São Paulo SABESP : MINUTES OF THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS’ MEETINGS HELD ON APRIL 28, 2023 - Form 6-K	23-05-26	PU
CITIC Telecom CPC becomes Versa Networks's First Greater China SASE & SD-WAN Managed Services Partner	23-05-24	AQ
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-05-15	AQ
UNION ELECTRIC CO : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-05-12	AQ
Rallybio Reports First Quarter 2023 Financial Results	23-05-09	BU
Resolutions from the Annual General Meeting of Novo Nordisk A/S	23-03-23	GL
Resolutions from the Annual General Meeting of Novo Nordisk A/S	23-03-23	GL
Novo Nordisk A/S Appoints Members of Committees	23-03-23	CI
Transcript : Novo Nordisk A/S - Shareholder/Analyst Call	23-03-23
Rallybio Reports Fourth Quarter and Full Year 2022 Financial Results	23-03-06	BU
Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia	23-03-06	BU

1234NextSee all

Companies (87)

LOCKHEED MARTIN CORPORATION 112 B $

Lockheed Martin Corporation specializes in the design, manufacturing and marketing of aeronautic, submarine, and aerospace systems. Net sales break down by activity as follows: - sale of aeronautic systems (40.7%): military and civilian aircraft, primari ...

LOCKHEED MARTIN CORPORATION 112 B $

JERÓNIMO MARTINS, SGPS, S.A. 14 020 M $

Jerónimo Martins, SGPS, S.A. is a Group that holds assets in the food sector, mostly in distribution, with market leadership positions in Poland and Portugal. In 2023, the Group recorded sales of 30.6 billion euros and an EBITDA of 2.2 billion euros. The ...

MARTIN MARIETTA MATERIALS, INC. 35 798 M $

Martin Marietta Materials, Inc. is America's 2nd largest producer of granulates and construction materials. Net sales break down by family of products as follows: - granulates and construction materials (94.5%): granulates (58.7% of net sales), ready mix ...

AHOLD DELHAIZE N.V. 30 074 M $

Ahold Delhaize N.V. is one of the world leaders in retailing. Net sales break down by activity as follows: - retail distribution in the United States (61.5%): operated, at the end of 2023, 2,048 stores broken down by names between Food Lion (1,108), Stop ...

JERÓNIMO MARTINS, SGPS, S.A. 14 020 M $

KONINKLIJKE AHOLD DELHAIZE N.V. 30 074 M $

UNITED SPIRITS LIMITED 10 080 M $

United Spirits Limited is India's largest spirits producer. The group provides Scotch (Black Dog, Dalmore, Jura and White & Mackay brands), Whisky (Antiquity, Bagpiper, McDowell's No.1 and McDowell's No.1 Platinum), rhum (Celebration rum), vodka (Pinky, R ...

AGRIMIN LIMITED 63 M $

Agrimin Limited is an Australia-based fertilizer development company. The principal activity of Company includes advancing the Mackay Potash Project in Western Australia. It operates in the area of mineral exploration and development in Western Australia. ...

1234Next

Insiders

Martin Mackay

Martin MacKay

Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

MacKay

James Morrison MacKay

James Morrison MacKay is currently the Chairman of True Product ID Technology (Beijing) Ltd.
He was previously the Chairman of MacKay Life Sciences, Inc. and Sure Trace Security Corp.
In 2007, he was the Chairman of True Product ID, Inc. and in 2006, he was the Interim Chairman of True Product ID, Inc.

Julie Mackay

Hugh MacKay

Hugh MacKay served as a Non-Executive Director at Stewart Milne Group Ltd.
from 1975 to 2019.

Adrian Lindsay Mackay

Mr. Adrian L.
Mackay is a Portfolio Manager & Fund Advisor at Freestyle Fund Services Co. LLC.
Prior to founding Freestyle Fund Services in September 2002, Mr. Mackay was employed as a Managing Director by ING Barings LLC and Furman Selz LLC and an Investment Banker by Kidder Peabody and Lehman Brothers Asset Management LLC.
He received his BSc in Electronic Engineering from The University of Southampton and his MBA from Tulane University.
He also completed the PADE at IESE Business School in Spain.

Niel MaCkay

No results for this search